153
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Acquired persistently complete remission by decitabine-based treatment for acute myeloid leukemia with the MLL-SEPT9 fusion gene

ORCID Icon, , , , , , , , & show all
Pages 3304-3307 | Received 31 Dec 2018, Accepted 11 May 2019, Published online: 01 Jul 2019
 

Ethical standards

Informed consent: Written informed consent was obtained from the patient for publication. The study was approved by the Ethics Committee of the West China Hospital of Sichuan University.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2019.1625044.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.